Delivery Order SPE2DB24D2205-SPE2DB24FDTZS
- Not listed
- This federal contract award, valued at $3,855.89, was granted to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S. This is a firm fixed price delivery order contract with a completion date of July 16, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large...
- This federal contract award is for the delivery of Contrave ER 8-90 mg tablets by Amerisourcebergen Drug Corp's Corporate Office division to the Defense Logistics Agency (DLA). The $4,570.45 firm-fixed price delivery order contract has a completion date of June 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $18,058.10 firm fixed-price delivery order has a completion date of March 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award is for the delivery of CONTRAVE ER 8/90MG 120, a prescription pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract has a firm fixed price of $28,603.83 and a completion date of September 4, 2024. It is a delivery order contract with no set-aside designation....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of pharmaceutical products, specifically CONTRAVE ER 8-90 MG TABLET 120S. The delivery order, valued at $4,076.96, is a Firm Fixed Price contract with a completion date of September 11, 2024. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is the prime contractor for this award. The contract does not...
- This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $11,693.25 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on July 11, 2024 with a completion date of July 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $9,471.05 Firm Fixed Price delivery order is for the supply of the prescription drug Contrave ER 8-90 mg tablets. The contract has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $4,063.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, with an ultimate completion date of August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to supply a wide range of medical...
- This federal contract award is to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S to the Defense Logistics Agency (DLA). The $1,590.62 firm-fixed-price delivery order contract has a completion date of September 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which enables the government to efficiently procure a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,976.75 delivery order is for the supply of 120 tablets of the drug Contrave ER 8-90 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to deliver a broad range of pharmaceutical products and medical supplies to DLA...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDTZSDelivery Order
This federal contract award is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $3,875.67 firm fixed-price delivery order has a completion date of May 13, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through December 2025 to deliver a range of medical commodities to support the Department of Defense. This contract does not have a set-aside designation. Amerisourcebergen's extensive supply chain and distribution expertise enable it to efficiently fulfill government pharmaceutical and medical product requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 5/10/24 |